VIRBAC SA (VIRP.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:VIRP - FR0000031577 - Common Stock
349.5 EUR
-7.5 (-2.1%)
VIRP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. VIRP has only an average score on both its financial health and profitability. VIRP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year VIRP was profitable.
- In the past year VIRP had a positive cash flow from operations.
- Each year in the past 5 years VIRP has been profitable.
- In the past 5 years VIRP always reported a positive cash flow from operatings.
1.2 Ratios
- VIRP has a Return On Assets of 8.00%. This is in the better half of the industry: VIRP outperforms 64.81% of its industry peers.
- Looking at the Return On Equity, with a value of 13.64%, VIRP is in line with its industry, outperforming 55.56% of the companies in the same industry.
- VIRP's Return On Invested Capital of 11.47% is in line compared to the rest of the industry. VIRP outperforms 55.56% of its industry peers.
- VIRP had an Average Return On Invested Capital over the past 3 years of 12.40%. This is in line with the industry average of 13.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROIC | 11.47% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
1.3 Margins
- With a Profit Margin value of 10.40%, VIRP perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
- VIRP's Profit Margin has improved in the last couple of years.
- The Operating Margin of VIRP (16.39%) is comparable to the rest of the industry.
- VIRP's Operating Margin has improved in the last couple of years.
- VIRP has a Gross Margin of 67.10%. This is comparable to the rest of the industry: VIRP outperforms 42.59% of its industry peers.
- In the last couple of years the Gross Margin of VIRP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% |
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
2. Health
2.1 Basic Checks
- VIRP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- VIRP has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VIRP has less shares outstanding
- The debt/assets ratio for VIRP is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 4.72 indicates that VIRP is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.72, VIRP is in the better half of the industry, outperforming 64.81% of the companies in the same industry.
- The Debt to FCF ratio of VIRP is 3.62, which is a good value as it means it would take VIRP, 3.62 years of fcf income to pay off all of its debts.
- VIRP has a better Debt to FCF ratio (3.62) than 62.96% of its industry peers.
- VIRP has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.22, VIRP is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.62 | ||
| Altman-Z | 4.72 |
ROIC/WACC1.48
WACC7.75%
2.3 Liquidity
- A Current Ratio of 1.96 indicates that VIRP should not have too much problems paying its short term obligations.
- VIRP has a Current ratio of 1.96. This is in the better half of the industry: VIRP outperforms 68.52% of its industry peers.
- A Quick Ratio of 1.04 indicates that VIRP should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.04, VIRP is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 20.61% over the past year.
- Measured over the past years, VIRP shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.20% on average per year.
- The Revenue has grown by 12.07% in the past year. This is quite good.
- VIRP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.29% yearly.
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
3.2 Future
- VIRP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
- VIRP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.53% yearly.
EPS Next Y3.93%
EPS Next 2Y7.81%
EPS Next 3Y8.82%
EPS Next 5Y10.81%
Revenue Next Year4.62%
Revenue Next 2Y5.05%
Revenue Next 3Y5.21%
Revenue Next 5Y5.53%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- VIRP is valuated rather expensively with a Price/Earnings ratio of 20.16.
- Compared to the rest of the industry, the Price/Earnings ratio of VIRP is on the same level as its industry peers.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, VIRP is valued a bit cheaper.
- A Price/Forward Earnings ratio of 16.44 indicates a correct valuation of VIRP.
- VIRP's Price/Forward Earnings ratio is in line with the industry average.
- VIRP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.16 | ||
| Fwd PE | 16.44 |
4.2 Price Multiples
- 70.37% of the companies in the same industry are more expensive than VIRP, based on the Enterprise Value to EBITDA ratio.
- VIRP's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.66 | ||
| EV/EBITDA | 10.87 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VIRP does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of VIRP may justify a higher PE ratio.
PEG (NY)5.12
PEG (5Y)0.87
EPS Next 2Y7.81%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
- VIRP has a yearly dividend return of 0.40%, which is pretty low.
- VIRP's Dividend Yield is comparable with the industry average which is at 1.59.
- With a Dividend Yield of 0.40, VIRP pays less dividend than the S&P500 average, which is at 1.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- 8.36% of the earnings are spent on dividend by VIRP. This is a low number and sustainable payout ratio.
DP8.36%
EPS Next 2Y7.81%
EPS Next 3Y8.82%
EPA:VIRP (1/19/2026, 7:00:00 PM)
349.5
-7.5 (-2.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-16 2025-10-16
Earnings (Next)01-19 2026-01-19/amc
Inst Owners25.28%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap2.93B
Revenue(TTM)1.40B
Net Income(TTM)145.29M
Analysts82.67
Price Target410.04 (17.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP8.36%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.19%
PT rev (3m)2.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.16 | ||
| Fwd PE | 16.44 | ||
| P/S | 2.1 | ||
| P/FCF | 32.66 | ||
| P/OCF | 14.91 | ||
| P/B | 2.75 | ||
| P/tB | 5.1 | ||
| EV/EBITDA | 10.87 |
EPS(TTM)17.34
EY4.96%
EPS(NY)21.26
Fwd EY6.08%
FCF(TTM)10.7
FCFY3.06%
OCF(TTM)23.44
OCFY6.71%
SpS166.55
BVpS126.95
TBVpS68.53
PEG (NY)5.12
PEG (5Y)0.87
Graham Number222.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROCE | 16.54% | ||
| ROIC | 11.47% | ||
| ROICexc | 12.64% | ||
| ROICexgc | 20.66% | ||
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% | ||
| FCFM | 6.43% |
ROA(3y)8.45%
ROA(5y)9.4%
ROE(3y)13.98%
ROE(5y)15.89%
ROIC(3y)12.4%
ROIC(5y)12.39%
ROICexc(3y)14.41%
ROICexc(5y)15%
ROICexgc(3y)23.78%
ROICexgc(5y)25.77%
ROCE(3y)17.85%
ROCE(5y)17.84%
ROICexgc growth 3Y-15.04%
ROICexgc growth 5Y-5.22%
ROICexc growth 3Y-12.77%
ROICexc growth 5Y7.18%
OM growth 3Y1%
OM growth 5Y7.93%
PM growth 3Y-0.75%
PM growth 5Y13.61%
GM growth 3Y12.2%
GM growth 5Y6.39%
F-Score7
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.62 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 166.76% | ||
| Cap/Sales | 7.65% | ||
| Interest Coverage | 45.52 | ||
| Cash Conversion | 67.09% | ||
| Profit Quality | 61.8% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 4.72 |
F-Score7
WACC7.75%
ROIC/WACC1.48
Cap/Depr(3y)125.08%
Cap/Depr(5y)109.34%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.5%
Profit Quality(3y)72.36%
Profit Quality(5y)71.26%
High Growth Momentum
Growth
EPS 1Y (TTM)20.61%
EPS 3Y8.97%
EPS 5Y23.2%
EPS Q2Q%-12.92%
EPS Next Y3.93%
EPS Next 2Y7.81%
EPS Next 3Y8.82%
EPS Next 5Y10.81%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y9.51%
Revenue growth 5Y8.29%
Sales Q2Q%5.03%
Revenue Next Year4.62%
Revenue Next 2Y5.05%
Revenue Next 3Y5.21%
Revenue Next 5Y5.53%
EBIT growth 1Y23.65%
EBIT growth 3Y10.61%
EBIT growth 5Y16.88%
EBIT Next Year33.24%
EBIT Next 3Y16.88%
EBIT Next 5Y14.26%
FCF growth 1Y7.29%
FCF growth 3Y29.91%
FCF growth 5Y10.8%
OCF growth 1Y46.62%
OCF growth 3Y26.32%
OCF growth 5Y14.75%
VIRBAC SA / VIRP.PA FAQ
What is the ChartMill fundamental rating of VIRBAC SA (VIRP.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA.
What is the valuation status of VIRBAC SA (VIRP.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for VIRBAC SA?
VIRBAC SA (VIRP.PA) has a profitability rating of 6 / 10.
Can you provide the financial health for VIRP stock?
The financial health rating of VIRBAC SA (VIRP.PA) is 6 / 10.
Can you provide the expected EPS growth for VIRP stock?
The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 3.93% in the next year.